Acalabrutinib is an oral inhibitor of Bruton tyrosine kinase that is used in the therapy of B cell malignancies including refractory mantle cell lymph


Acalabrutinib is an oral inhibitor of Bruton tyrosine kinase that is used in the therapy of B cell malignancies including refractory mantle cell lymphoma. 3d illustration


Size: 7000px × 3855px
Photo credit: © Igor Petrushenko / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: 3d, acalabrutinib, atomic, atoms, blocker, bruton, btk, cancer, chemical, chemistry, chronic, cll, composition, designation, enzyme, illustration, inhibitor, kinase, leukemia, lymphocytic, lymphoma, medicine, model, molecular, molecule, oncology, orphan, pharma, pharmacy, rendering, tumor, tyrosine